glp-1 news today oct 2 2025 Weight-Loss Drug Demonstration Begins July 2026 GLP-1 Pipeline Update: May 2025

In mouse models, dual agonism had superior efficacy for weight loss and glucose control compared to a GLP-1RA alone 9 , with additive effects of the GIPR proposed to act through signaling in beta cells 10 , alpha cells 11 , the CNS (central nervous system) 12,13 and adipocytes 14

CENTRAL EFFECTS MC4R Hypothalamic MC4R The MC4R receptor is expressed in the paraventricular (PVN) and arcuate nuclei of the hypothalamus, which are integrators of sexual motivation, feeding control, and autonomic regulation

Pentadecapeptide BPC 157 tendon-fibroblast model study

The scientific community is increasingly recognizing the role of targeted nutritional interventions in post-viral recovery